Q2 INTERIM REPORT April-June 2024
Read more
Mentice has received a 2.26 million USD order for simulation solutions from a top 20 global MedTech company
Read more

Mentice receives an order of EUR 1,733,200 for simulation solutions from a world leading MedTech company

Friday, December 22, 2023

Mentice (publ), Gothenburg, a world leader in simulation solutions for image-guided interventional therapies, announced today that a global healthcare technology leader and existing customer of Mentice, has signed an agreement to acquire Mentice VIST® simulation solutions for EUR 1,733,200. The majority of the Mentice VIST® systems are to be deployed in the main APAC markets.

“We are pleased to announce this contract as part of our continued growth in the Medical Device Industry. This is a significant order that underlines our ongoing commitment to supporting physician’s procedural and device adoption initiatives through our global medical device clients.”, states Göran Malmberg, CEO of Mentice AB.

The order will be recognized for order value in 2023 while the majority of the revenue will be recognized in 2024.

Q2 DELÅRSRAPPORT April-Juni 2024
Läs mer
Mentice får en order på simuleringslösningar värd 2,26 miljoner USD från ett topp 20 globalt medtech bolag
Läs mer

Mentice receives an order of EUR 1,733,200 for simulation solutions from a world leading MedTech company

Friday, December 22, 2023

Mentice (publ), Gothenburg, a world leader in simulation solutions for image-guided interventional therapies, announced today that a global healthcare technology leader and existing customer of Mentice, has signed an agreement to acquire Mentice VIST® simulation solutions for EUR 1,733,200. The majority of the Mentice VIST® systems are to be deployed in the main APAC markets.

“We are pleased to announce this contract as part of our continued growth in the Medical Device Industry. This is a significant order that underlines our ongoing commitment to supporting physician’s procedural and device adoption initiatives through our global medical device clients.”, states Göran Malmberg, CEO of Mentice AB.

The order will be recognized for order value in 2023 while the majority of the revenue will be recognized in 2024.